Page last updated: 2024-11-05

pirinixic acid and Disease Exacerbation

pirinixic acid has been researched along with Disease Exacerbation in 2 studies

pirinixic acid: structure

Research Excerpts

ExcerptRelevanceReference
" Glutathione S-transferase placental (GST-P)-negative hepatocellular altered foci (HAF), hepatocellular adenoma (HCA), and hepatocellular carcinoma (HCC) were generated by two initiation-promotion models with N-nitrosodiethylamine (NDEN) and peroxisome proliferators, Wy-14,643 and clofibrate."3.72alpha(2)-Macroglobulin: a novel cytochemical marker characterizing preneoplastic and neoplastic rat liver lesions negative for hitherto established cytochemical markers. ( Fukushima, S; Kikuchi, K; Kushida, M; Mikami, N; Morimura, K; Oeda, K; Okuno, Y; Ozaki, K; Saito, K; Sukata, T; Sumida, K; Uwagawa, S, 2004)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sukata, T1
Uwagawa, S1
Ozaki, K1
Sumida, K1
Kikuchi, K1
Kushida, M1
Saito, K1
Morimura, K1
Oeda, K1
Okuno, Y1
Mikami, N1
Fukushima, S1
Archer, DC1
Frkanec, JT1
Cromwell, J1
Clopton, P1
Cunard, R1

Other Studies

2 other studies available for pirinixic acid and Disease Exacerbation

ArticleYear
alpha(2)-Macroglobulin: a novel cytochemical marker characterizing preneoplastic and neoplastic rat liver lesions negative for hitherto established cytochemical markers.
    The American journal of pathology, 2004, Volume: 165, Issue:5

    Topics: Adenoma; Alkylating Agents; alpha-Macroglobulins; Animals; Anticholesteremic Agents; Biomarkers, Tum

2004
WY14,643, a PPARalpha ligand, attenuates expression of anti-glomerular basement membrane disease.
    Clinical and experimental immunology, 2007, Volume: 150, Issue:2

    Topics: Animals; Anti-Glomerular Basement Membrane Disease; Chemokine CCL2; Cytokines; Disease Progression;

2007